However, injections of IL-25 in obese mouse models display enhance UCP1 expression, M2 macrophage polarization, and overall improvements in glucose homeostasis (84), showing that activation of ILC2s in adipose may provide a route of treatment for T2DM. The gene discussed is UCP1; the disease is type 2 diabetes mellitus.